B9: Can bacteria survive in the intracellular space of osteoblasts?
B10: Do intracellular bacteria play a role in propagating musculoskeletal infections?
B11: How should antimicrobial properties of an orthopedic implant be evaluated?
B12: What are the minimum data set for studying orthopedic infections?
B13: Are monoclonal antibodies capable of eradicating biofilms in orthopedic infections?
B14: Is there a role for the use of proteolytic enzymes to treat orthopedic infections?
B15: Are we certain that biofilms are the main challenge of treating implant associated infections?
.
B16: Are ultrasonic debridement devices useful for removal of biofilm in orthopedic infections?
B17: Does biofilm form in the synovial fluid?
B18: Does the concept of viable but not culturable (VBNC) apply to orthopedic infections?
B20: Does biofilm have different affinities for different surfaces?
B23: Are there any methods to detect biofilms in vivo?
B24: Are biofilms carcinogenic or associated with bone tumors?
B1: How can the knowledge about the microenvironment of bone and joint infection be improved?
B3: Is there an immune proteome in PJI?
B25: What are the best strategies to prevent biofilm formation and maturation?
B26: Can electric fields be used to detach and destroy biofilm?
B27: Are there any antibiotics with anti-biofilm properties?
B28: Is Dithiothreitol useful for disrupting biofilm in synovial fluid?
B31: What conditions must exist for a bacteria to become pathogenic within a joint? Table 1
HK21: Should saline be injected into a joint during a dry aspiration(tap)?
HK22: Is there a role for synovial calprotectin for diagnosis of PJI?
HK23: Does the pH of infected synovial fluid vary from that of uninfected synovial fluid?
HK25: When taking culture of a joint, how many samples should be taken?
HK26: What is the optimal duration for holding cultures in patients with PJI?
HK28: Should intraoperative culture be obtained in ALL patients undergoing revision arthroplasty?
HK29: Should fungal and acid-fast bacilli cultures be done in all culture samples taken from joints?
HK30: Do immunocompromised patients with PJI have a different microorganism profile?
HK31: In patients with polymicrobial PJI, is there a role for determining the dominant pathogen?
HK32: Is there a role for a specialized diagnostic algorithm in patients with culture negative PJIs?
HK33: Is there a role for histopathological testing of joint tissue in the diagnosis of PJI?
HK34: What thresholds for neutrophils should we use in diagnosis of PJI?
HK36: What is the clinical significance of polymicrobial PJI when using molecular techniques?
HK38: Is there a role for antibody testing for micro-organisms in the diagnosis of PJI?
HK40: Do plain films play a role in diagnosis of PJI?
HK41: What imaging has the best ability to identify osteomyelitis in patients with SSI/PJI?
HK42: Is there a role for bone scan in diagnosis of PJI?
HK43: Is there a role for the use of MRI in diagnosis of PJI?
HK44: Is there a role for the use of CT scan for diagnosis of PJI?
HK45: Is aspiration of the joint necessary prior to reimplantation?
HK48: What patients are candidates for DAIR?
HK50: Should DAIR be offered to patients with acute hematogenous PJI? Table1 Table2 Table3 Figure1
HK51: What is the optimal surgical protocol for performing DAIR in patients with acute PJI?
HK1: Do intraarticular injections prior to primary joint arthroplasty increase the risk of SSI/PJI?
HK4: Is the rate of PJI higher in patients who have prior UKA and undergoing conversion TKA?
HK5: Does surgical approach influence the rate of PJI after THA?
HK10: What is the definition of periprosthetic infection?
HK12: How can uninfected seroma be differentiated from collection pus in patients with SSI/PJI??
HK17: Is there a role for serum procalcitonin for diagnosis of PJI?
HK53: Is there a role for arthroscopy in performing DAIR for patients with acute PJI?
HK54: Is there a role for repeat DAIR in patients with acute PJI of hip or knee?
HK57: Does a prior DAIR influence the outcome of subsequent exchange arthroplasty in patients with PJI? TABLE,FIG1,FIG2
HK58: Does the type of infective organism influence the success rate of DAIR?
HK59: Are there absolute contraindications to performing one stage exchange arthroplasty?
HK61: Can one-stage exchange be performed in patients with culture negative PJI?
HK62: Can one stage exchange be done in patients with fungal PJI?
HK63: Can one stage exchange be done in patients with an active sinus tract?
HK64: Should collateral ligaments be removed during one-stage exchange arthroplasty for PJI of knee?
HK67: Is there a role for sub radical exchange (leaving some implants) arthroplasty in patients with chronic PJI? TABLES
HK68: Is there a role for abbreviated two stage exchange arthroplasty?
HK69: What is the optimal management of infected hemiarthroplasty of the hip?
HK70: What is the optimal management of infected unicondylar arthroplasty of the knee?
HK71: For how long does antibiotic elude from cement spacers? Table 1, Table2, Table3
HK75: Is there a role for 1.5 stage exchange arthroplasty?
HK76: What, if any, are the indications for exchange of cement spacers?
HK80: How soon after treatment of patients with PJI can success be declared?
HK81: What is the optimal prophylactic antibiotic for patients undergoing primary arthroplasty?
HK85: Is there a role for intraosseous administration of prophylactic antibiotics?
G38: Should prophylactic antibiotics be repeated in patients with excessive blood loss?
G40: How many pairs of gloves should the surgical team wear during major orthopedic procedures?
G41: How often should gloves be changed during major orthopedic procedures?
G43: Does operative time influence the incidence of SSI/PJI after major orthopedic surgery?
G1: Is there a genetic predisposition to developing SSI/PJI after major orthopedic procedures?
G6: What is the optimal nasal decolonization agent for patients undergoing major orthopedic surgery?
G7: Should administration of prophylactic antibiotics be weight-based?
G8: Should prophylactic antibiotics be altered for patients who are carriers of MRSA?
G9: What is the optimal antibiotic prophylaxis for patients with penicillin allergy?
G57: Is there a role for bacteriophage therapy in treatment of orthopedic infections?
G58: Is there a role for phage lysins in treatment of patients with orthopedic infections?
G64: Is there a role for hydrophobic wound coverage in patients undergoing major orthopedic surgery?
G65: Is there a role for the use of INPWT in patients undergoing major orthopedic surgery?
G72: Is there a role for sonification of implants obtained during revision surgery?
G74: What are risk factors for development of Mycobacterial infections?
G75: Is there a role for dual antibiotic prophylaxis for patients undergoing orthopedic procedures?
G78: Can oral antimicrobials be used for the treatment of implant associated infections?
G86: Should antimicrobial treatment target MIC or MBEC of organisms?
G92: Is there any antibiotic in development that has better bone penetration?
G93: Should immune status of patients with orthopedic infections be evaluated?
G94: Is there a role for immunotherapy in patients with orthopedic implant associated infections?
G96: Should implant associated orthopedic infections be treated in specialized centers?
G97: Is mortality increased in patients with orthopedic implant associated infections?
G99: How can we capture the physical and psychological impact of orthopedic infections on patients?
G100: Is the epidemiology of orthopedic implant associated infections changing?
G101: Can registries be used to conduct research on orthopedic infections?
G102: Does public reporting of SSI rates for institutions contribute towards prevention of SSI?
Sh26: Is arthroscopic biopsy/culture efficacious for the diagnosis of PJI?
Sh30: Should a negative control sample be sent at the time of revision surgery?
Sh45: Should all cultures be sent for mycobacterial testing?
Sh47: Skip
Sh49: Is there a role for bone scan in diagnosis of PJI?
Sh50: Is there a role for the use of MRI in diagnosis of PJI?
Sh51: Does the use of CT SPECT scans help in the diagnosis of shouldr PJI?
Sh52: Is there a role of CT PET scans in the diagnosis of shoulder PJI?
Sh58: What is the role of IV vs oral antibiotics in the treatment of acute shoulder PJI? Does the treatment change based on the diagnostic criteria (Definite vs Probable vs Possible)?
Sh60: Should bacterial virulence determine antibiotic treatment?
Sh63: What is the optimal oral abx for chronic suppression?
Sh64: What is the optimal oral or IV antibiotic treatment in cases of culture negatve PJI?
Sh66: What is the optimal surgical protocol for performing DAIR in patients with acute PJI?
Sh77: Should bone graft or cement be removed during treatment of acute shoulder PJI?
Sh78: Should bone graft or cement be removed in treatment for subacute or chronic shoulder PJI?
Sh1: Is there evidence for sex/gender specific approaches to prevention of PJI?
Sh2: Is there a role for prolonged peri-operative antibiotics to prevent acute post-operative PJI?
Sh4: Is testosterone supplementation associated with increased risk of shoulder PJI?
Sh5: Should testosterone supplementation be stopped prior to for a period of time after arthroplasty? If so, when should it be restarted?
Sh6: How does surgical time influence risk of PJI?
Sh7: How shoulder antibiotics be managed in outpatient shoulder arthroplasty?
Sh9: Does the use of pyrocarbon prevent shoulder PJI?
Sh11: Is there efficacy of antibiotic powder during skin closure on PJI prevention?
Sh12: What is the association between hgb a1c and shoulder PJI?
Sh13: Should a bovie be used for skin incision?
Sh14: Should iodine impregnated drapes be used?
Sh15: Should hair be clipped from the shoulder?
Sh22: Does the type of shoulder arthroplasty affect the rate of acute post-operative PJI?
Sp21: Does the use of braces help in reducing pain, deformity and collapse in conservative therapy?
Sp25: During follow up, to assess radiological healing, is MRI alone enough or a plain radiograph and CT scan also necessary and How often should radiological investigations be done to confirm healing in spinal tuberculosis?
Sp1: Should all patients with spine tuberculosis be routinely tested for human immunodeficiency virus?
Sp7: Are there specific imaging features which can prognosticate treatment outcomes?
Sp40: Are Modic changes representative of primary endplate infections?
Sp42: What is the most reliable and accurate classification for primary spinal infection?
Sp47: Do all pyogenic psoas abscesses need to be drained?
Sp49: What is the optimal management of patients with spinal infection and inconclusive biopsy?
Sp65: What is the role of endoscopic transforaminal debridement in pyogenic spinal infections?
Sp73: Role of Next-Generation Sequencing in identification of pathogen in spinal infection?
